159 related articles for article (PubMed ID: 37323605)
21. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes.
Wróel T; Mazur G; Dziegiel P; Jeleń M; Szuba A; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2006; 44(1):43-7. PubMed ID: 16584091
[TBL] [Abstract][Full Text] [Related]
22. The angiogenic switch for vascular endothelial growth factor-A and cyclooxygenase-2 in prostate carcinoma: correlation with microvessel density, androgen receptor content and Gleason grade.
Gyftopoulos K; Vourda K; Sakellaropoulos G; Perimenis P; Athanasopoulos A; Papadaki E
Urol Int; 2011; 87(4):464-9. PubMed ID: 21912077
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer.
Strohmeyer D; Rössing C; Bauerfeind A; Kaufmann O; Schlechte H; Bartsch G; Loening S
Prostate; 2000 Nov; 45(3):216-24. PubMed ID: 11074523
[TBL] [Abstract][Full Text] [Related]
24. [Vascular endothelial growth factor (VEGF) serum concentration in non-Hodgkin's lymphoma patients].
Wróbel T; Mazur G; Usnarska-Zubkiewicz L; Kuliczkowski K
Pol Arch Med Wewn; 2004 Aug; 112(2):919-23. PubMed ID: 15675266
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma.
Ho CL; Sheu LF; Li CY
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):316-21. PubMed ID: 12607599
[TBL] [Abstract][Full Text] [Related]
26. VEGF and CD 34: A correlation between tumor angiogenesis and microvessel density-an immunohistochemical study.
Kukreja I; Kapoor P; Deshmukh R; Kulkarni V
J Oral Maxillofac Pathol; 2013 Sep; 17(3):367-73. PubMed ID: 24574654
[TBL] [Abstract][Full Text] [Related]
27. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases.
Quintanilla-Martínez L; Lome-Maldonado C; Ott G; Gschwendtner A; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Blood; 1997 Jan; 89(2):644-51. PubMed ID: 9002968
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas.
Paydas S; Ergin M; Erdogan S; Seydaoglu G
Leuk Res; 2008 Sep; 32(9):1424-30. PubMed ID: 18282597
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
Raica M; Cimpean AM; Anghel A
Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus-associated extranodal non-Hodgkin's lymphoma of the sinonasal tract and nasopharynx in Thailand.
Mitarnun W; Suwiwat S; Pradutkanchana J
Asian Pac J Cancer Prev; 2006; 7(1):91-4. PubMed ID: 16629523
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients.
Ludovini V; Sidoni A; Pistola L; Bellezza G; De Angelis V; Gori S; Mosconi AM; Bisagni G; Cherubini R; Bian AR; Rodinò C; Sabbatini R; Mazzocchi B; Bucciarelli E; Tonato M; Colozza M
Breast Cancer Res Treat; 2003 Sep; 81(2):159-68. PubMed ID: 14572158
[TBL] [Abstract][Full Text] [Related]
32. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma.
Stewart M; Talks K; Leek R; Turley H; Pezzella F; Harris A; Gatter K
Histopathology; 2002 Mar; 40(3):253-60. PubMed ID: 11895491
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma.
Fukushima N; Satoh T; Sano M; Tokunaga O
Leuk Lymphoma; 2001 Aug; 42(4):709-20. PubMed ID: 11697501
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma.
Karavasilis V; Malamou-Mitsi V; Briasoulis E; Tsanou E; Kitsou E; Pavlidis N
Int J Gynecol Cancer; 2006; 16 Suppl 1():241-6. PubMed ID: 16515598
[TBL] [Abstract][Full Text] [Related]
35. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of angiogenic cytokines in childhood Hodgkin lymphoma.
Citak EC; Oguz A; Karadeniz C; Akyurek N
Pathol Res Pract; 2008; 204(2):89-96. PubMed ID: 18207652
[TBL] [Abstract][Full Text] [Related]
38. Microvessel density is a prognostic marker of human gastric cancer.
Zhao HC; Qin R; Chen XX; Sheng X; Wu JF; Wang DB; Chen GH
World J Gastroenterol; 2006 Dec; 12(47):7598-603. PubMed ID: 17171787
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.
Suzuki S; Dobashi Y; Hatakeyama Y; Tajiri R; Fujimura T; Heldin CH; Ooi A
BMC Cancer; 2010 Nov; 10():659. PubMed ID: 21118571
[TBL] [Abstract][Full Text] [Related]
40. Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas.
Vacca A; Ribatti D; Fanelli M; Costantino F; Nico B; Di Stefano R; Serio G; Dammacco F
Leuk Lymphoma; 1996 Aug; 22(5-6):473-81. PubMed ID: 8882961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
